Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557

Documenti analoghi

• Multiple-Dose Pharmacokinetics and Safety of the New Antifungal Triazole BAL4815 after Intravenous Infusion and Oral Administration of Its Prodrug, BAL8557, in Healthy Volunteers
  di: Schmitt-Hoffmann, Anne, et al.
  Pubblicazione: (2006)
• Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic Impairment
  di: Desai, Amit, et al.
  Pubblicazione: (2016)
• Single-Ascending-Dose Pharmacokinetics and Safety of the Novel Broad-Spectrum Antifungal Triazole BAL4815 after Intravenous Infusions (50, 100, and 200 Milligrams) and Oral Administrations (100, 200, and 400 Milligrams) of Its Prodrug, BAL8557, in Healthy Volunteers
  di: Schmitt-Hoffmann, Anne, et al.
  Pubblicazione: (2006)
• Multiple-Dose Pharmacokinetics and Safety of a Novel Broad-Spectrum Cephalosporin (BAL5788) in Healthy Volunteers
  di: Schmitt-Hoffmann, Anne, et al.
  Pubblicazione: (2004)
• Single-Dose Pharmacokinetics and Safety of a Novel Broad-Spectrum Cephalosporin (BAL5788) in Healthy Volunteers
  di: Schmitt-Hoffmann, Anne, et al.
  Pubblicazione: (2004)